A detailed history of Rothschild Investment LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 382 shares of MRNA stock, worth $15,704. This represents 0.0% of its overall portfolio holdings.

Number of Shares
382
Previous 660 42.12%
Holding current value
$15,704
Previous $78.4 Million 67.43%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$63.64 - $125.14 $17,691 - $34,788
-278 Reduced 42.12%
382 $25.5 Million
Q2 2024

Jul 30, 2024

BUY
$101.21 - $166.61 $66,798 - $109,962
660 New
660 $78.4 Million
Q1 2024

Jul 31, 2024

BUY
$85.37 - $115.44 $5,549 - $7,503
65 Added 17.43%
438 $46.7 Million
Q4 2023

Jul 31, 2024

SELL
$69.51 - $104.43 $19,949 - $29,971
-287 Reduced 43.48%
373 $37.1 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $16.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.